Trusted by 100,000+ International Patients
CyberKnife Treatment: Italy vs Singapore
Cost, Quality & Recovery Compared
$10000
Italy Starting Cost
$25000
Singapore Starting Cost
See how these top medical tourism destinations compare for CyberKnife Treatment.
| Comparison Factor | Italy | Singapore | Winner |
|---|---|---|---|
| Average Cost (in USD) | 10000 - 22000 | 25000 - 50000 | Italy |
| Success Rate (Min and Max) | 85% - 95% local tumour control (varies by tumour type) | 88% – 96% local tumor control (varies by tumor type) | Singapore |
| Advanced Technology | CyberKnife M6 / VSI robotic radiosurgery systems with real-time tumour tracking, adaptive radiation planning, and high-precision image-guided radiotherapy in major European oncology centres | CyberKnife M6 / VSI systems with real-time tumor tracking, adaptive radiation planning, and advanced imaging integration in major cancer centers. | Both Equal |
| JCI Accredited Hospitals | 25+ | 20+ | Italy |
| Visa Process | Schengen Medical Visa / Short-Stay Visa (7-15 working days) | Short-Term Visit Pass / Medical Visa (5–10 working days) | Both Equal |
*Costs are estimates and may vary based on hospital, complexity, and package inclusions. See detailed cost breakdown below
Understand exactly where your money goes. Both countries offer all-inclusive packages, but here's how the costs typically break down.
Best for Budget-Conscious Patients
Offered Package Price (Additional Cost Excluded)
Best for Flexible Donor Requirements
Offered Package Price (Additional Cost Excluded)
Top Hospitals: Farrer Park Hospital
Want a personalized cost estimate based on your specific condition?
Get Your Free QuoteBoth Italy and Singapore maintain world-class healthcare standards with internationally accredited hospitals and highly trained medical professionals.
Hospitals accredited by Joint Commission International (JCI) and national Italian healthcare authorities with specialised radiation oncology departments and multidisciplinary tumour boards.
Local tumour control rates generally range between 85–95%, depending on tumour type such as brain, spine, lung, liver, or prostate.
Radiation therapy services in Italy are regulated by the Italian Ministry of Health and follow strict European Union radiation safety regulations and medical device standards.
JCI-accredited hospitals and internationally recognised oncology centres with multidisciplinary tumour boards.
Reported local tumour control rates are typically 88–96%, depending on tumour type such as brain, spine, lung, or prostate.
Radiation therapy services are regulated by the Singapore Ministry of Health (MOH) with strict radiation safety standards and medical device regulations.
| Quality Metric | Italy | Singapore |
|---|---|---|
Accredited Hospitals | 25+ | 20+ |
Average Success Rate | 85–95% | 88–96% |
Top Speciality Hospital Hubs | Rome, Milan, Bologna | - |
Both countries have highly qualified and experienced medical specialists trained at premier institutions worldwide. Here's what sets them apart.
Radiation Oncologists
High annual stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) treatment volumes in major oncology institutes.
Radiation oncologists
High annual SRS/SBRT treatment volumes
All surgeons listed on Medigence are verified for their medical license, board certifications, hospital affiliations, and patient outcomes. We conduct background checks and regularly update our database to ensure you're connected with the best medical professionals.
Beyond medical excellence, your comfort during treatment matters. Compare the patient experience at top hospitals in both destinations.
World-class hospitals, exceptional value
Leading oncology hospitals in Italy are equipped with CyberKnife robotic radiosurgery systems, high-resolution MRI and CT imaging for treatment planning, advanced radiation safety infrastructure, and multidisciplinary tumour boards that guide personalised cancer therapy.
Luxury healthcare experience
Singapore’s leading oncology hospitals are equipped with CyberKnife robotic radiosurgery systems, high-resolution imaging for precise treatment planning, advanced radiation safety infrastructure, and multidisciplinary tumour boards to guide personalised cancer treatment.
Plan your medical journey with confidence. Here's everything you need to know about travel, visas, and accommodation in both countries.
We provide end-to-end travel assistance including visa facilitation, airport pickups, hotel bookings near your hospital, and local support throughout your stay. Our patient coordinators handle all logistics so you can focus on recovery.
Understanding the recovery process helps you plan better. Here's what to expect after CyberKnife Treatment in both countries.
CyberKnife radiosurgery is a non-invasive treatment performed without surgical incisions.
Patients may remain locally during treatment sessions for monitoring.
Travel is generally allowed once the radiation oncologist confirms treatment stability.
Most patients gradually return to normal activities within a few weeks, depending on the treated organ.
In-person follow-ups recommended at 3, 6, 12 months. Telemedicine available.
CyberKnife treatment is typically performed as an outpatient procedure without surgical incisions.
Patients may remain locally for observation during treatment sessions.
Travel is usually permitted once the radiation oncologist confirms clinical stability.
Most patients gradually return to normal activities within a few weeks, depending on the treatment site.
Comprehensive telemedicine follow-up program. Return visits at 6, 12 months if possible.
CyberKnife Treatment recipients require lifelong immunosuppressant medications. Ensure you have a plan for obtaining these medications and regular blood monitoring in your home country before traveling abroad for surgery.
Every medical procedure carries risks. We believe in complete transparency so you can make a fully informed decision about your CyberKnife Treatment journey.
Risk of bleeding or infection is very low as CyberKnife is a non-invasive procedure.
Some patients may experience mild swelling or discomfort near the treated area.
Radiation effects may cause temporary fatigue or mild tissue irritation.
Rare complications may include radiation-related tissue inflammation depending on the treated organ.
Patients may experience fatigue, headache, nausea, or mild skin irritation depending on the treatment site.
The right choice depends on your specific situation. Here's a clear guide to help you decide which destination aligns with your needs.
Patients diagnosed with small to moderate-sized tumours in the brain, spine, lung, liver, pancreas, or prostate who require highly precise stereotactic radiation therapy and may not be ideal candidates for conventional surgery.
Patients diagnosed with small to moderate-sized tumors in the brain, spine, lung, liver, pancreas, or prostate who require highly precise stereotactic radiation therapy and may not be ideal candidates for conventional surgery.
Our medical tourism experts can analyze your case and recommend the best destination based on your medical history and budget.
Follow this step-by-step framework to make the right choice for your CyberKnife Treatment journey.
Consult a radiation oncologist to determine whether CyberKnife radiosurgery is appropriate based on tumour type, size, and location.
Treatment costs may vary depending on the number of sessions, imaging requirements, and hospital category.
CyberKnife therapy is usually completed within 1–5 sessions over several days, so travel and accommodation should be planned accordingly.
Provide MRI scans, CT imaging, biopsy reports, and previous treatment history for accurate treatment planning.
Regular imaging follow-ups are required to evaluate treatment response and long-term outcomes.
Let our medical tourism experts guide you through the process. We'll help you:
No obligation • Free consultation • Response within 24 hours
Surgical Oncologist
15 Years of Experience
Dr. Prateek Varshney is a renowned Surgical Oncologist. He has experience of more than 15+ years in surgical Oncology. He is currently practicing as a consultant at Metro Mass Hospital and Cancer Institute. He was also previously associated as a consultant with Sir Ganga Ram Hospital and as a professor at Gujarat Cancer Research Institute. View More
